Types segmentation classifies Egg Alternatives by their underlying formulation, each influencing functional performance and market positioning. Plant‑based products—derived from legumes (mung bean, chickpea), cereals (rice, oat), or nuts—dominate with an estimated 55 % share, owing to their established supply chains and consumer familiarity. Fermented egg analogues, produced through microbial fermentation of protein precursors, hold roughly 15 % of sales; they deliver superior emulsification and foaming properties, targeting premium bakery and specialty food applications. Algal options, primarily based on spirulina or chlorella extracts, capture about 10 % as they offer high‑quality protein and natural colorants, appealing to health‑focused segments. Synthetic or cell‑based egg substitutes, still emerging, account for the remaining 20 % and are concentrated in research‑intensive firms pursuing scalable bioreactor production; their growth potential is linked to regulatory approvals and cost reductions. By quantifying these type categories, analysts can assess technology adoption curves and forecast shifts in the overall market taxonomy for egg alternatives.